Covered recipient · General Payments record
ZACHARIAH NEAL WEILENMAN
Allopathic & Osteopathic Physicians Physical Medicine & Rehabilitation Pain Medicine
General Payments · PY2021–2024
$4,646.77
- Reported across 54 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $522.42 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | $153.32 | 3 |
| ABBVIE INC. | $129.17 | 4 |
| Averitas Pharma Inc. | $117.87 | 2 |
| Abbott Laboratories | $60.64 | 2 |
| Merz Pharmaceuticals, LLC | $35.74 | 1 |
| Bioventus LLC | $25.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $32.22 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124880510 | CMS |
| Abbott Laboratories | $28.42 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124880512 | CMS |
| ABBVIE INC. | $30.54 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106318877 | CMS |
| ABBVIE INC. | $32.20 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106318879 | CMS |
| ABBVIE INC. | $33.21 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106318881 | CMS |
| ABBVIE INC. | $33.22 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106318883 | CMS |
| Averitas Pharma Inc. | $14.75 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133450682 | CMS |
| Averitas Pharma Inc. | $103.12 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133450686 | CMS |
| Bioventus LLC | $25.68 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137451364 | CMS |
| Boston Scientific Corporation | $136.47 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092414784 | CMS |
| Boston Scientific Corporation | $0.93 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092414780 | CMS |
| Boston Scientific Corporation | $15.92 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092414782 | CMS |
| Merz Pharmaceuticals, LLC | $35.74 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137956143 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.